Autor: |
Bauer S; TissUse GmbH, Berlin, Germany. sophie.bauer@tissuse.com., Wennberg Huldt C; Bioscience Diabetes, Cardiovascular and Metabolic Diseases, IMED Biotech Unit, AstraZeneca, Gothenburg, Sweden., Kanebratt KP; DMPK, Cardiovascular and Metabolic Diseases, IMED Biotech Unit, AstraZeneca, Gothenburg, Sweden., Durieux I; TissUse GmbH, Berlin, Germany., Gunne D; TissUse GmbH, Berlin, Germany., Andersson S; DMPK, Cardiovascular and Metabolic Diseases, IMED Biotech Unit, AstraZeneca, Gothenburg, Sweden., Ewart L; Drug Safety and Metabolism, IMED Biotech Unit, AstraZeneca, Cambridge, UK., Haynes WG; Bioscience Diabetes, Cardiovascular and Metabolic Diseases, IMED Biotech Unit, AstraZeneca, Gothenburg, Sweden., Maschmeyer I; TissUse GmbH, Berlin, Germany., Winter A; TissUse GmbH, Berlin, Germany., Ämmälä C; Bioscience Diabetes, Cardiovascular and Metabolic Diseases, IMED Biotech Unit, AstraZeneca, Gothenburg, Sweden., Marx U; TissUse GmbH, Berlin, Germany., Andersson TB; DMPK, Cardiovascular and Metabolic Diseases, IMED Biotech Unit, AstraZeneca, Gothenburg, Sweden.; Department of Physiology and Pharmacology, Section of Pharmacogenetics, Karolinska Institutet, Stockholm, Sweden. |